Compass Therapeutics Inc.

NASDAQ: CMPX · Real-Time Price · USD
2.98
0.03 (1.02%)
At close: Aug 15, 2025, 3:59 PM
2.97
-0.34%
After-hours: Aug 15, 2025, 04:10 PM EDT

Compass Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
850K n/a n/a n/a
Cost of Revenue
n/a 1.89M 1.9M 1.62M
Gross Profit
850K -1.89M -1.9M -1.62M
Operating Income
-56.63M -50.36M -41.66M -81.88M
Interest Income
7.3M n/a 2.36M 29K
Pretax Income
-49.38M -42.49M -39.23M -82.18M
Net Income
-49.38M -42.49M -36.8M -82.55M
Selling & General & Admin
15.13M 11.05M 11.66M 10.93M
Research & Development
42.34M 37.42M 30M 20.34M
Other Expenses
n/a n/a n/a 50.62M
Operating Expenses
57.48M 48.47M 41.66M 31.26M
Interest Expense
n/a n/a 2.36M 370K
Selling & Marketing Expenses
n/a 11.04M n/a n/a
Cost & Expenses
57.48M 50.36M 41.66M 31.26M
Income Tax Expense
n/a n/a -2.43M 370K
Shares Outstanding (Basic)
137.11M 127.03M 105.19M 62.87M
Shares Outstanding (Diluted)
137.11M 127.03M 105.19M 62.87M
EPS (Basic)
-0.36 -0.33 -0.35 -1.31
EPS (Diluted)
-0.36 -0.33 -0.35 -1.31
EBITDA
-54.87M -48.47M -37.39M -29.61M
EBIT
-56.63M -50.36M n/a n/a
Depreciation & Amortization
1.75M 1.89M 1.9M 1.62M